Interius Biotherapeutics
Elaine Youngman is a Principal Scientist at Interius BioTherapeutics with a background in biochemistry, cell, and molecular biology. Elaine has extensive experience in research and academia, from directing research labs to establishing COVID-19 surveillance testing labs. Elaine has collaborated with cross-functional teams, conducted innovative research on RNA-centered gene regulation, and trained laboratory staff. Elaine's dedication to scientific discovery and operational efficiency is apparent throughout their career.
Interius Biotherapeutics
1 followers
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.